European Journal of Medicinal Chemistry published new progress about Antitumor agents. 20776-50-5 belongs to class bromides-buliding-blocks, and the molecular formula is C7H6BrNO2, Name: 2-Amino-4-bromobenzoic acid.
Li, Peng; Liu, Ying; Yang, Hua; Liu, Hong-Min published the artcile< Design, synthesis, biological evaluation and structure-activity relationship study of quinazolin-4(3H)-one derivatives as novel USP7 inhibitors>, Name: 2-Amino-4-bromobenzoic acid, the main research area is piperidinylmethyl amino quinazolinone preparation USP7 inhibitor antitumor docking SAR; Gastric cancer; Inhibitors; Quinazolin-4(3H)-one; SAR; USP7; Ubiquitination.
The design, synthesis and biol. evaluation of novel I [R1 = pyrrolyl, Ph, pyridinyl, etc.] and II [R2 = Et, furanyl, dimethylaminomethylene, etc.;R3 = H, methyl] as potent USP7 inhibitors was reported. This results indicated that the compounds II [R2 = pyrrolidinylmethylene, dimethylaminomethylene;R3 = H, methyl] exhibited the greatest potency against the USP7 catalytic domain, with IC50 values of 4.86μM and 1.537μM, resp. Ub-AMC assays further confirmed IC50 values of 5.048μM and 0.595μM for II [R2 = pyrrolidinylmethylene, dimethylaminomethylene; R3 = H, methyl] resp. MTT assays indicated that gastric cancer MGC-803 cells were more sensitive to these compounds than BGC-823 cells. Flow cytometry anal. revealed that II [R2 = pyrrolidinylmethylene; R3 = H ] restricted cancer cell growth at the G0/G1 and S phases and inhibited the proliferation and clone formation of MGC-803 cells. Further biochem. experiments indicated that II [R2 = pyrrolidinylmethylene; R3 = H ] decreased the MDM2 protein level and increased the levels of the tumor suppressors p53 and p21 in a dose-dependent manner. Docking studies predicted that solvent exposure of the side chains of II [R2 = pyrrolidinylmethylene, dimethylaminomethylene; R3 = H, methyl] would uniquely form hydrogen bonds with Met407 of USP7. Addnl., II [R2 = pyrrolidinylmethylene; R3 = H ] exhibited a remarkable anticancer effect in a zebrafish gastric cancer MGC-803 cell model. Results demonstrated that I [R1 = pyrrolyl, Ph, pyridinyl, etc.] and II [R2 = Et, furanyl, dimethylaminomethylene etc.; R3 = H, methyl] were suitable as leads for the development of novel USP7 inhibitors and especially for anti-gastric cancer drugs.
European Journal of Medicinal Chemistry published new progress about Antitumor agents. 20776-50-5 belongs to class bromides-buliding-blocks, and the molecular formula is C7H6BrNO2, Name: 2-Amino-4-bromobenzoic acid.
Referemce:
Bromide – Wikipedia,
bromide – Wiktionary